UK markets closed

Simcere Pharmaceutical Group Ltd (S2P.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
0.68000.0000 (0.00%)
At close: 08:15AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
714,761
714,761
930,868
1,507,096
669,534
-
Depreciation & amortisation
309,594
309,594
283,647
251,807
222,329
-
Stock-based compensation
12,119
12,119
138,290
62,392
32,797
-
Change in working capital
-946,751
-946,751
79,642
-801,723
-462,178
-
Inventory
-376,639
-376,639
-116,992
-8,330
-35,461
-
Other working capital
-828,807
-828,807
676,094
-411,458
-256,110
-
Other non-cash items
5,598
5,598
-25,459
2,561
73,335
-
Net cash provided by operating activities
151,048
151,048
1,354,099
-201,970
96,731
-
Cash flows from investing activities
Investments in property, plant and equipment
-979,855
-979,855
-678,005
-209,488
-352,841
-
Acquisitions, net
-87,320
-87,320
0
-53,053
0
-
Purchases of investments
-68,485
-68,485
-344,786
-1,489,402
-103,772
-
Sales/maturities of investments
949,097
949,097
824,287
451,124
764,567
-
Other investing activities
-51,953
-51,953
-
-
9,886
166,538
Net cash used for investing activities
1,087,807
1,087,807
68,306
-435,503
529,083
-
Net change in cash
344,021
344,021
668,724
-2,262,004
2,979,436
-
Cash at beginning of period
1,658,312
1,658,312
974,464
3,270,241
354,804
-
Cash at end of period
2,007,162
2,007,162
1,658,312
973,139
3,270,241
-
Free cash flow
Operating cash flow
151,048
151,048
1,354,099
-201,970
96,731
-
Capital expenditure
-979,855
-979,855
-678,005
-209,488
-352,841
-
Free cash flow
-828,807
-828,807
676,094
-411,458
-256,110
-